当前位置:
X-MOL 学术
›
J. Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Can Patients with Controlled Rheumatoid Arthritis Taper Methotrexate from Targeted Therapy and Sustain Remission? A Systematic Review and Meta-analysis.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-08-15 , DOI: 10.3899/jrheum.220152 Charis F Meng 1 , Diviya A Rajesh 2 , Deanna P Jannat-Khah 3 , Bridget Jivanelli 4 , Vivian P Bykerk 1
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-08-15 , DOI: 10.3899/jrheum.220152 Charis F Meng 1 , Diviya A Rajesh 2 , Deanna P Jannat-Khah 3 , Bridget Jivanelli 4 , Vivian P Bykerk 1
Affiliation
To determine the risk of not being able to sustain remission after tapering MTX from targeted therapy in patients with controlled RA.
中文翻译:
类风湿性关节炎患者能否通过靶向治疗逐渐减量甲氨蝶呤并维持缓解?系统评价和荟萃分析。
确定在控制性 RA 患者中通过靶向治疗逐渐减少 MTX 后不能维持缓解的风险。
更新日期:2022-08-15
中文翻译:
类风湿性关节炎患者能否通过靶向治疗逐渐减量甲氨蝶呤并维持缓解?系统评价和荟萃分析。
确定在控制性 RA 患者中通过靶向治疗逐渐减少 MTX 后不能维持缓解的风险。